Protective mucosal immunity against SARS-CoV-2 after heterologous systemic prime-mucosal boost immunization | Nature Communications
Viruses | August 2021 - Browse Articles
Vaccines | Special Issue : Advances in Vaccine Development and Immunotherapies
Vaccines | Free Full-Text | Vaccination with Deglycosylated Modified Hemagglutinin Broadly Protects against Influenza Virus Infection in Mice and Ferrets
Potential Use of Exosomes as Diagnostic Biomarkers and in Targeted Drug Delivery: Progress in Clinical and Preclinical Applications | ACS Biomaterials Science & Engineering
Vaccines | April 2022 - Browse Articles
Promoting safe working environments by tracking vaccination status • Fusion Learning Partners
FAQ: DIVA vaccines and diagnostics - Epizone
Protective mucosal immunity against SARS-CoV-2 after heterologous systemic prime-mucosal boost immunization | Nature Communications
Vaccines | Free Full-Text | Vaccination with Deglycosylated Modified Hemagglutinin Broadly Protects against Influenza Virus Infection in Mice and Ferrets
Omicron BA.1 breakthrough infection drives cross-variant neutralization and memory B cell formation against conserved epitopes | Science Immunology
Omicron BA.1 breakthrough infection drives cross-variant neutralization and memory B cell formation against conserved epitopes | Science Immunology
Vaccines | December 2020 - Browse Articles
Vaccines | Free Full-Text | Assessing the Protective Dose of a Candidate DIVA Vaccine against Classical Swine Fever
Protective mucosal immunity against SARS-CoV-2 after heterologous systemic prime-mucosal boost immunization | Nature Communications
Frontiers | Development of Recombinant Protein-Based Vaccine Against Classical Swine Fever Virus in Pigs Using Transgenic Nicotiana benthamiana
Performance of the currently available DIVA real‐time PCR assays in classical and recombinant lumpy skin disease viruses - Byadovskaya - 2021 - Transboundary and Emerging Diseases - Wiley Online Library
Vaccines | Free Full-Text | Assessing the Protective Dose of a Candidate DIVA Vaccine against Classical Swine Fever
Vaccines | Free Full-Text | Vaccination with Deglycosylated Modified Hemagglutinin Broadly Protects against Influenza Virus Infection in Mice and Ferrets
Refining the approach to vaccines against influenza A viruses with pandemic potential | Future Virology
Omicron BA.1 breakthrough infection drives cross-variant neutralization and memory B cell formation against conserved epitopes | Science Immunology
Protective mucosal immunity against SARS-CoV-2 after heterologous systemic prime-mucosal boost immunization | Nature Communications
Vaccines | March 2022 - Browse Articles
